Cargando…

Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance

AIM: The aim of the study was to validate the expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer (NSCLC), and to evaluate its clinicopathological and prognostic significance. METHODS: We first conducted a meta-analysis on the mRNA profiling data sets of NSCLC in the Oncomine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Chao, Chen, Yan, Zhang, Weiwei, Zhang, Jianrong, Xu, Yulian, Li, Wenjie, Chen, Sunxiao, Deng, Anmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596122/ https://www.ncbi.nlm.nih.gov/pubmed/23525678 http://dx.doi.org/10.2147/OTT.S41283

Ejemplares similares

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
por: Aubele, M, et al.
Publicado: (2008)

A chromosomal passenger complex protein signature model predicts poor prognosis for non-small-cell lung cancer
por: Xia, Rong, et al.
Publicado: (2015)

Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer
por: Gong, Juejun, et al.
Publicado: (2021)

The Alternative Splice Variant of Protein Tyrosine Kinase 6 Negatively Regulates Growth and Enhances PTK6-Mediated Inhibition of β-Catenin
por: Brauer, Patrick M., et al.
Publicado: (2011)

Prognostic impact of PTK6 expression in triple negative breast cancer
por: Chen, Yuexia, et al.
Publicado: (2023)

Protein tyrosine kinase, PtkA, is required for Mycobacterium tuberculosis growth in macrophages
por: Wong, Dennis, et al.
Publicado: (2018)

In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues
por: Aubele, M, et al.
Publicado: (2010)

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas
por: Aubele, M, et al.
Publicado: (2007)

PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer
por: Wozniak, Darren J., et al.
Publicado: (2017)

Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma
por: Lee, Jasmine Y., et al.
Publicado: (2023)

Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers
por: Qiu, Luping, et al.
Publicado: (2018)

Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: A systematic review and meta-analysis
por: Zhu, Lingling, et al.
Publicado: (2019)

Characterization of Atypical Protein Tyrosine Kinase (PTK) Genes and Their Role in Abiotic Stress Response in Rice
por: Elangovan, Allimuthu, et al.
Publicado: (2020)

Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF
por: Shin, Won-Sik, et al.
Publicado: (2019)

Protein Tyrosine Kinase 7 (PTK7) as a Predictor of Lymph Node Metastases and a Novel Prognostic Biomarker in Patients with Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes
por: Tupper, J., et al.
Publicado: (2011)

Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer
por: Motono, Nozomu, et al.
Publicado: (2021)

Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma
por: Zou, Ren-Chao, et al.
Publicado: (2019)

The protein tyrosine kinases EpsB and PtkA differentially affect biofilm formation in Bacillus subtilis
por: Gerwig, Jan, et al.
Publicado: (2014)

The Prognostic Significance of the Histological Types in Patients With Nonsmall Cell Lung Cancer ≤2 cm
por: Hao, Bo, et al.
Publicado: (2021)

Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer
por: Kim, Gun-Jik, et al.
Publicado: (2017)

Gene Characteristics and Prognostic Values of m(6)A RNA Methylation Regulators in Nonsmall Cell Lung Cancer
por: Li, Na, et al.
Publicado: (2021)

Overexpression of PTK6 predicts poor prognosis in bladder cancer patients
por: Xu, Xue-lian, et al.
Publicado: (2017)

Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer
por: Wang, Lili, et al.
Publicado: (2022)

Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling
por: Shin, Won-Sik, et al.
Publicado: (2023)

Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer
por: Liu, Chaoqun, et al.
Publicado: (2021)

Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance
por: Jiang, Zhipeng, et al.
Publicado: (2022)

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of patients with nonsmall cell lung cancer
por: Li, Xi, et al.
Publicado: (2023)

PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival
por: Irie, Hanna Y., et al.
Publicado: (2010)

The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib(®))
por: GAUMANN, ANDREAS K.A., et al.
Publicado: (2014)

TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in Gliomas
por: Guo, Jianrong, et al.
Publicado: (2023)

Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses
por: Chen, Yanru, et al.
Publicado: (2022)

Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro
por: Burmi, Rajpal S., et al.
Publicado: (2022)

Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer
por: Grimminger, Peter P., et al.
Publicado: (2009)

Long-range replica exchange molecular dynamics guided drug repurposing against tyrosine kinase PtkA of Mycobacterium tuberculosis
por: Nagpal, Priya, et al.
Publicado: (2020)

PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
por: Ito, Koichi, et al.
Publicado: (2017)

EGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis
por: Yuan, Jin-Qiu, et al.
Publicado: (2017)

Protein tyrosine kinase 6 regulates activation of SRC kinase
por: Alwanian, Wanian M., et al.
Publicado: (2022)

Protein Tyrosine Kinase 7 (PTK7) Promotes Metastasis in Hepatocellular Carcinoma via SOX9 Regulation and TGF-β Signaling
por: Wong, Tsz Lam Matthew, et al.
Publicado: (2022)

SUN-007 Discovery of Novel Signaling Pathways Downstream of PTK6 in TNBC Models
por: Dwyer, Amy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fbmaqlv1gf380bgk3c45haivoq